These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29082265)

  • 21. An Approach to Identify and Characterize a Subunit Candidate Shigella Vaccine Antigen.
    Pore D; Chakrabarti MK
    Methods Mol Biol; 2016; 1403():433-44. PubMed ID: 27076146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiplexed immunoassay to assess Shigella-specific antibody responses.
    Kaminski RW; Clarkson K; Kordis AA; Oaks EV
    J Immunol Methods; 2013 Jul; 393(1-2):18-29. PubMed ID: 23583496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization of Mice with a Live Transconjugant Shigella Hybrid Strain Induced Th1 and Th17 Cell-Mediated Immune Responses and Confirmed Passive Protection Against Heterologous Shigellae.
    Nag D; Koley H; Sinha R; Mukherjee P; Sarkar C; Withey JH; Gachhui R
    Scand J Immunol; 2016 Feb; 83(2):92-101. PubMed ID: 26478541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunogenic SigA enterotoxin of Shigella flexneri 2a binds to HEp-2 cells and induces fodrin redistribution in intoxicated epithelial cells.
    Al-Hasani K; Navarro-Garcia F; Huerta J; Sakellaris H; Adler B
    PLoS One; 2009 Dec; 4(12):e8223. PubMed ID: 20011051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reverse vaccinology approach for the identification and characterization of outer membrane proteins of
    Leow CY; Kazi A; Hisyam Ismail CMK; Chuah C; Lim BH; Leow CH; Banga Singh KK
    Clin Exp Vaccine Res; 2020 Jan; 9(1):15-25. PubMed ID: 32095437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
    Phalipon A; Sansonetti P
    Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of Plesiomonas shigelloides strains that share type-specific antigen with Shigella flexneri 6 and common group 1 antigen with Shigella flexneri spp. and Shigella dysenteriae 1.
    Albert MJ; Ansaruzzaman M; Qadri F; Hossain A; Kibriya AK; Haider K; Nahar S; Faruque SM; Alam AN
    J Med Microbiol; 1993 Sep; 39(3):211-7. PubMed ID: 8366520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach.
    Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
    Infect Genet Evol; 2017 Nov; 55():151-158. PubMed ID: 28919551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein.
    Alam A; Ali S; Ahamad S; Malik MZ; Ishrat R
    Immunology; 2016 Dec; 149(4):386-399. PubMed ID: 27485738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivated and subunit vaccines to prevent shigellosis.
    Kaminski RW; Oaks EV
    Expert Rev Vaccines; 2009 Dec; 8(12):1693-704. PubMed ID: 19943764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial epitopes involved in the induction of reactive arthritis.
    Stieglitz H; Fosmire S; Lipsky PE
    Am J Med; 1988 Dec; 85(6A):56-8. PubMed ID: 2462352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis and immunology in shigellosis: applications for vaccine development.
    Hale TL; Keren DF
    Curr Top Microbiol Immunol; 1992; 180():117-37. PubMed ID: 1380415
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.
    Mel D; Gangarosa EJ; Radovanovic ML; Arsic BL; Litvinjenko S
    Bull World Health Organ; 1971; 45(4):457-64. PubMed ID: 4948417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of recombinant vaccine candidate molecule against Shigella infection.
    Chitradevi STS; Kaur G; Sivaramakrishna U; Singh D; Bansal A
    Vaccine; 2016 Oct; 34(44):5376-5383. PubMed ID: 27591952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Passive immunity with multi-serotype heat-killed Shigellae in neonatal mice.
    Barman S; Koley H; Nag D; Shinoda S; Nair GB; Takeda Y
    Microbiol Immunol; 2014 Aug; 58(8):463-6. PubMed ID: 24909404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
    Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
    J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection.
    Phalipon A; Tanguy M; Grandjean C; Guerreiro C; Bélot F; Cohen D; Sansonetti PJ; Mulard LA
    J Immunol; 2009 Feb; 182(4):2241-7. PubMed ID: 19201878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.